Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thayná Mendonça Avelino"'
Autor:
Maiara Ferreira Terra, Marta García-Arévalo, Thayná Mendonça Avelino, Karina Y. Degaki, Murilo de Carvalho, Felipe Rafael Torres, Angela Saito, Ana Carolina Migliorini Figueira
Publikováno v:
Biomolecules, Vol 13, Iss 4, p 632 (2023)
Since the removal of thiazolidinediones (TZDs) from the market, researchers have been exploring alternative anti-diabetic drugs that target PPARγ without causing adverse effects while promoting insulin sensitization by blocking serine 273 phosphoryl
Externí odkaz:
https://doaj.org/article/760c04f2a05f4b7695147c7a2630ed3b
Autor:
Thayna Mendonca Avelino, Marta García-Arévalo Provencio, Luis Antonio Peroni, Romênia Ramos Domingues, Felipe Rafael Torres, Paulo Sergio Lopes de Oliveira, Adriana Franco Paes Leme, Ana Carolina Migliorini Figueira
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0303612 (2024)
Obesity, a burgeoning global health crisis, has tripled in prevalence over the past 45 years, necessitating innovative research methodologies. Adipocytes, which are responsible for energy storage, play a central role in obesity. However, most studies
Externí odkaz:
https://doaj.org/article/4e0f62cc225a49d2a08a404f9d07ba9d
Autor:
Thayna Mendonca Avelino, Marta García-Arévalo, Felipe Rafael Torres, Marieli Mariano Goncalves Dias, Romenia Ramos Domingues, Murilo de Carvalho, Matheus de Castro Fonseca, Vanessa Kiraly Thomaz Rodrigues, Adriana Franco Paes Leme, Ana Carolina Migliorini Figueira
Publikováno v:
SLAS Discovery, Vol 27, Iss 3, Pp 167-174 (2022)
Worldwide obesity, defined as abnormal or excessive fat accumulation that may result in different comorbidities, is considered a pandemic condition that has nearly tripled in the last 45 years. Most studies on obesity use animal models or adipocyte m
Externí odkaz:
https://doaj.org/article/3673b4389c264402af2afbb4cc88e57d
Autor:
Carolina Bonet Bub, Beatriz Moraes Martinelli, Thayna Mendonca Avelino, Ana Claudia Goncalez, Maria de Lourdes Barjas-Castro, Vagner Castro
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 35, Iss 4, Pp 252-255 (2013)
BACKGROUND: Immune platelet refractoriness is mainly caused by human leukocyte antigen antibodies (80-90% of cases) and, to a lesser extent, by human platelet antigen antibodies. Refractoriness can be diagnosed by laboratory tests and patients should
Externí odkaz:
https://doaj.org/article/80e8ccb1713d46e1a72ed2bef0547be8